NEW YORK, Feb 13 – Bioinformatics tool provider Pharmacopeia said Tuesday it had promoted Michael Stapleton to the position of chief operating officer for the company’s software division and Stephen Spearman to the position of chief operating officer for the company’s drug discovery business.

The Princeton, NJ-based company decided to create two COO positions for the different divisions following the resignation of Saiid Zarrabian in December.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.